Search results for " 2015"
								 					Article
				
				Labeling of Biosimilars
								Feb 01, 2015
	
	By Sean Milmo
	
	BioPharm International
	The European Medicines Agency (EMA) has reached a key stage in the lengthy process of creating a regulatory framework for the development and…								
								 					Article
				
				Driving Improved Access to Biosimilars
								In a formal statement in December 2018 (2), former FDA commissioner Scott Gottlieb referred to insulin prices, which have increased nearly 600% between 2001 and 2015, with the average US list price ri…								
								 					Article
				
				Impact of Media Components on CQAs of Monoclonal Antibodies
								
	The authors review how media components modulate the quality of monoclonal antibody products. 
	By Anurag Rathore, Rajinder Kaur, Dipankar Borgayari 
	
	
	
	
	Recombinant protein products have…								
								 					Article
				
				Downstream Processing for Cell-Based Therapies
								17, 2015). 
			
			17. F. Masri, Cell Gene Ther. Insights 2 (4), 463–471 (2016). 
			
			18. N. Hutchinson et al., Biotechnol. Bioeng. 95 (3), 483–491 (2006). 
			
			19. N.B. Jackson, J.M. Liddell, a…								
								 					Article
				
				Mechanistic Modeling of Preparative Ion-Exchange Chromatography
								21, 2015). 
			
			4. N. Borg et al., J. Chromatogr. A 1359, 170–181 (2014). 
			
			5. E. von Lieres et al., Chemie Ingenieur Technik 86 (9), 1626–1626 (2014). 
			
			6. T. Hahn et al., J. Chem. Edu…								
								 					Article
				
				Efforts Accelerate to Streamline Postapproval Change Process
								To spur the Q12 process, FDA in 2015 issued a draft guidance on defining and reporting ECs (2). The guidance describes which elements of a control strategy could be considered ECs necessary to assure …								
								 					Article
				
				Perfusion in the 21st Century
								Woodcock, “Introducing New Technology in Pharmaceutical Manufacturing,” presented in Integrated Continuous Manufacturing II, San Francisco, CA, 2015. 
	
	9. J. Pollock, et al., Biotechnology and Bioen…								
								 					Article
				
				An Integrated Approach to Ensure the Viral Safety of Biotherapeutics
								1, 2015), pp. 719. 
							
							8. European Pharmacopoeia, Monograph: Bovine Serum, 01/2008:2262, pp. 1506–1507. 
							
							9. ICH, Q5A (R1) Quality of Biotechnological Products: Viral Safety …								
								 					Article
				
				GMP Challenges for Advanced Therapy Medicinal Products
								…ene- and cell-therapy products and tissue-engineered treatments, was due to be completed in November 2015. The guidelines, which will be drawn up by the European Commission, however, are taking a lon…								
								 					Article
				
				Implications of Cell Culture Conditions on Protein Glycosylation
								
	The authors present a review of the techniques commonly used for glycosylation analysis.
	By Michiel E. Ultee, PhD, Dr. Richard Easton
	
	This article reviews the implications of cell-culture co…